HPSE in Ocular Herpes Infection
HPSE 在眼部疱疹感染中的应用
基本信息
- 批准号:10753834
- 负责人:
- 金额:$ 42.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAlzheimer&aposs DiseaseAntiviral AgentsBindingBiological AssayBlindnessCause of DeathCell DeathCellsComplexCorneaCorneal DiseasesCyclic AMP-Dependent Protein KinasesCytoprotectionDNA DamageDNA RepairDataDiseaseEncephalitisEnvironmentEpithelial CellsExtracellular MatrixEyeEye InfectionsEye diseasesFatal OutcomeFundingGenetic TranscriptionGenotypeGrowth FactorHeparitin SulfateHerpesviridae InfectionsHerpesvirus 1Herpetic KeratitisHumanImmunoprecipitationImpairmentIn VitroIncidenceInfectionInflammationInflammatoryInvestigationKnowledgeMediatingMultiple SclerosisMusNervous SystemNeurodegenerative DisordersOcular PathologyPathologyPathway interactionsPhenocopyPhenotypePhosphorylationPhosphotransferasesProductionPrognosisProtein IsoformsProtein KinaseProteinsProteomicsProto-Oncogene Proteins c-aktPublishingRoleSeveritiesSeverity of illnessTestingTimeTissuesUlcerUp-RegulationVascular PermeabilitiesViralViral EncephalitisViral PathogenesisViral load measurementVirulence FactorsVirusVirus Replicationangiogenesiscorneal epitheliumcytokineexperimental studyheparanasein vivoinhibitorknock-downmetabolomicsmimicrymouse modelneovascularizationnerve damagenew therapeutic targetsmall moleculetranscriptomics
项目摘要
From the previous R01 funding period we have generated compelling new evidence that human Heparanase-1
(HPSE), a heparan sulfate (HS) endoglycosidase, is a virulence factor responsible for triggering angiogenesis
and inflammation in the eye during herpes simplex virus type-1 (HSV-1) infection. Our in vivo studies have shown
that HPSE presence can significantly increase HSV-1 replication and severity of ocular disease with poor
prognosis. Investigation of transcriptional and proteomic landscapes revealed a multitude of non-enzymatic roles
for HPSE during HSV-1 infection and identified new druggable targets. Upon further investigation, we found that
the significance of HPSE in corneal infection may not be limited to promoting viral pathogenesis only, but also in
the induction of inflammatory cell death in a protein kinase B (Akt) dependent manner. Making things even more
interesting and potentially more significant, our new preliminary data suggests that HPSE and Akt2 isoform
phenocopy each other both in inflammatory cell death and deficiency in virus production. Therefore, based on
our published observations of HPSE’s non-enzymatic roles and preliminary results, we hypothesize an important,
yet interconnected regulatory role for HPSE and Akt2 in HSV-1 mediated ocular inflammation, nerve damage,
and the resultant vision loss. We propose that their inhibition through small molecules can reduce disease
severity and viral replication in the eye and reduce the incidences of viral encephalitis. This proposal will focus
on understanding HPSE driven inflammatory cell death mechanisms and the role for Akt2 during HSV-1
replication, spread and disease pathology in the cornea. Successful completion of our studies will identify new
and more effective HPSE and Akt2 inhibitors that can reduce inflammation as well as virus load without causing
any adverse effects. Results generated through the proposed experiments will be broadly relevant, as aberrant
HPSE activity has been implicated in a wide array of ocular pathologies and other neurodegenerative diseases
and disorders such as multiple sclerosis and Alzheimer’s Disease.
从之前的 R01 资助期中,我们获得了令人信服的新证据,表明人类 Heparanase-1
(HPSE) 是一种硫酸乙酰肝素 (HS) 糖苷内切酶,是负责触发血管生成的毒力因子
以及 1 型单纯疱疹病毒 (HSV-1) 感染期间眼部炎症。我们的体内研究表明
HPSE 的存在可以显着增加 HSV-1 的复制和眼部疾病的严重程度
预后。对转录和蛋白质组景观的研究揭示了多种非酶作用
HSV-1 感染期间的 HPSE 并确定了新的药物靶点。经过进一步调查,我们发现
HPSE 在角膜感染中的重要性可能不仅限于促进病毒发病机制,还包括
以蛋白激酶 B (Akt) 依赖性方式诱导炎症细胞死亡。让事情变得更加美好
有趣且可能更重要的是,我们的新初步数据表明 HPSE 和 Akt2 亚型
在炎症细胞死亡和病毒产生缺陷方面彼此表现型相似。因此,基于
根据我们发表的对 HPSE 非酶作用的观察结果和初步结果,我们假设一个重要的,
HPSE 和 Akt2 在 HSV-1 介导的眼部炎症、神经损伤、
以及由此导致的视力丧失。我们认为通过小分子抑制它们可以减少疾病
严重程度和病毒在眼睛中的复制,并减少病毒性脑炎的发病率。该提案将重点
了解 HPSE 驱动的炎症细胞死亡机制以及 Akt2 在 HSV-1 期间的作用
角膜中的复制、传播和疾病病理学。成功完成我们的研究将发现新的
以及更有效的 HPSE 和 Akt2 抑制剂,可以减少炎症和病毒载量,而不会引起
任何不良影响。通过所提出的实验产生的结果将具有广泛的相关性,因为异常
HPSE 活性与多种眼部病变和其他神经退行性疾病有关
以及多发性硬化症和阿尔茨海默病等疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEEPAK SHUKLA其他文献
DEEPAK SHUKLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEEPAK SHUKLA', 18)}}的其他基金
A small molecule inhibitor of HSV genital infections
HSV 生殖器感染的小分子抑制剂
- 批准号:
10205994 - 财政年份:2018
- 资助金额:
$ 42.28万 - 项目类别:
A small molecule inhibitor of HSV genital infections
HSV 生殖器感染的小分子抑制剂
- 批准号:
9763444 - 财政年份:2018
- 资助金额:
$ 42.28万 - 项目类别:
A new molecular therapy against ocular herpes
一种针对眼部疱疹的新分子疗法
- 批准号:
10557908 - 财政年份:2015
- 资助金额:
$ 42.28万 - 项目类别:
A new molecular therapy against ocular herpes
一种针对眼部疱疹的新分子疗法
- 批准号:
10363614 - 财政年份:2015
- 资助金额:
$ 42.28万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 42.28万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 42.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 42.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 42.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 42.28万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




